BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27441640)

  • 1. In Silico Design and Experimental Validation of siRNAs Targeting Conserved Regions of Multiple Hepatitis C Virus Genotypes.
    ElHefnawi M; Kim T; Kamar MA; Min S; Hassan NM; El-Ahwany E; Kim H; Zada S; Amer M; Windisch MP
    PLoS One; 2016; 11(7):e0159211. PubMed ID: 27441640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs.
    Krönke J; Kittler R; Buchholz F; Windisch MP; Pietschmann T; Bartenschlager R; Frese M
    J Virol; 2004 Apr; 78(7):3436-46. PubMed ID: 15016866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of IRES containing 5'UTR of HCV genotype 3a using siRNAs.
    Khaliq S; Jahan S; Pervaiz A; Ali Ashfaq U; Hassan S
    Virol J; 2011 May; 8():221. PubMed ID: 21569449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Hepatitis C Virus in Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence in Viral IRES Pseudoknot.
    Moon JS; Lee SH; Kim EJ; Cho H; Lee W; Kim GW; Park HJ; Cho SW; Lee C; Oh JW
    PLoS One; 2016; 11(1):e0146710. PubMed ID: 26751678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hepatitis C virus infection in cell culture by small interfering RNAs.
    Chevalier C; Saulnier A; Benureau Y; Fléchet D; Delgrange D; Colbère-Garapin F; Wychowski C; Martin A
    Mol Ther; 2007 Aug; 15(8):1452-62. PubMed ID: 17505476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome.
    Takigawa Y; Nagano-Fujii M; Deng L; Hidajat R; Tanaka M; Mizuta H; Hotta H
    Microbiol Immunol; 2004; 48(8):591-8. PubMed ID: 15322339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral therapy: inhibition of Hepatitis C Virus expression by RNA interference directed against the NS5B region of the viral genome.
    Trejo-Avila L; Elizondo-González R; Trujillo-Murillo Kdel C; Zapata-Benavides P; Rodríguez-Padilla C; Rivas-Estilla AM
    Ann Hepatol; 2007; 6(3):174-80. PubMed ID: 17786145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HCV subgenomic replicons by siRNAs derived from plasmids with opposing U6 and H1 promoters.
    Korf M; Meyer A; Jarczak D; Beger C; Manns MP; Krüger M
    J Viral Hepat; 2007 Feb; 14(2):122-32. PubMed ID: 17244252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of hepatitis C virus translation and subgenomic replication by siRNAs directed against highly conserved HCV sequence and cellular HCV cofactors.
    Korf M; Jarczak D; Beger C; Manns MP; Krüger M
    J Hepatol; 2005 Aug; 43(2):225-34. PubMed ID: 15964661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model.
    Kim M; Shin D; Kim SI; Park M
    Virus Res; 2006 Dec; 122(1-2):1-10. PubMed ID: 16979254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small interfering RNA targeted to stem-loop II of the 5' untranslated region effectively inhibits expression of six HCV genotypes.
    Prabhu R; Garry RF; Dash S
    Virol J; 2006 Nov; 3():100. PubMed ID: 17129382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Optimized Inhibitor RNAs Allowing Multisite-Targeting of the HCV Genome.
    Romero-López C; Lahlali T; Berzal-Herranz B; Berzal-Herranz A
    Molecules; 2017 May; 22(5):. PubMed ID: 28531161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transcriptional inhibition of hepatitis C virus replication through small interference RNA.
    Ali Ashfaq U; Ansar M; Sarwar MT; Javed T; Rehman S; Riazuddin S
    Virol J; 2011 Mar; 8():112. PubMed ID: 21388559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small interfering RNA targeted to hepatitis C virus 5' nontranslated region exerts potent antiviral effect.
    Kanda T; Steele R; Ray R; Ray RB
    J Virol; 2007 Jan; 81(2):669-76. PubMed ID: 17079316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of Combinatorial Lentiviral Vectors Expressing Multiple Anti-Hepatitis C Virus shRNAs and Their Validation on a Novel HCV Replicon Double Reporter Cell Line.
    Elbadawy HM; Mohammed Abdul MI; Aljuhani N; Vitiello A; Ciccarese F; Shaker MA; Eltahir HM; Palù G; Di Antonio V; Ghassabian H; Del Vecchio C; Salata C; Franchin E; Ponterio E; Bahashwan S; Thabet K; Abouzied MM; Shehata AM; Parolin C; Calistri A; Alvisi G
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32962117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs.
    Yokota T; Sakamoto N; Enomoto N; Tanabe Y; Miyagishi M; Maekawa S; Yi L; Kurosaki M; Taira K; Watanabe M; Mizusawa H
    EMBO Rep; 2003 Jun; 4(6):602-8. PubMed ID: 12740604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence-specific cleavage of hepatitis C virus RNA by DNAzymes: inhibition of viral RNA translation and replication.
    Roy S; Gupta N; Subramanian N; Mondal T; Banerjea AC; Das S
    J Gen Virol; 2008 Jul; 89(Pt 7):1579-1586. PubMed ID: 18559927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs.
    Randall G; Grakoui A; Rice CM
    Proc Natl Acad Sci U S A; 2003 Jan; 100(1):235-40. PubMed ID: 12518066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel hepatitis C virus reporter replicon cell lines enable efficient antiviral screening against genotype 1a.
    Robinson M; Yang H; Sun SC; Peng B; Tian Y; Pagratis N; Greenstein AE; Delaney WE
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3099-106. PubMed ID: 20516274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.